Kutlu O Ülgen (Kutlu O Ulgen, Kutlu O Ulgen, Kutlu Ulgen)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 27

Top Venues

ACS biomaterials science & engineering

Molecules (Basel, Switzerland)

Molecular informatics

Biomedicines

Boğaziçi University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Boğaziçi University

Turkey

Professor :: Chemical Engineering

Publications

Asu Busra Temizer, Gökçe Uludoğan, Rıza Özçelik, Taha Koulani, Elif Ozkirimli, Kutlu O Ülgen, Nilgün Karalı, Arzucan Özgür
Exploring data-driven chemical SMILES tokenization approaches to identify key protein-ligand binding moieties. Molecular informatics 43 (3) (2024)
Ilkay Irem Ozbek, Hale Saybasili, Kutlu O Ülgen
Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma. ACS biomaterials science & engineering 10 (5) (2024)
Ilkay Irem Ozbek, Hale Saybasili, Kutlu O Ülgen
Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma. ACS biomaterials science & engineering (2024)
Ilkay Irem Ozbek, Hale Saybasili, Kutlu O Ülgen
Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma. ACS biomaterials science & engineering 10 (5) (2024)
Asu Busra Temizer, Gökçe Uludoğan, Rıza Özçelik, Taha Koulani, Elif Ozkirimli, Kutlu O Ülgen, Nilgün Karalı, Arzucan Özgür
Exploring data-driven chemical SMILES tokenization approaches to identify key protein-ligand binding moieties. Molecular informatics (2024)
Asu Busra Temizer, Gökçe Uludoğan, Rıza Özçelik, Taha Koulani, Elif Ozkirimli, Kutlu O Ülgen, Nilgün Karalı, Arzucan Özgür
Exploring data-driven chemical SMILES tokenization approaches to identify key protein-ligand binding moieties. Molecular informatics (2024)
Mustafa Sertbas, Kutlu O Ülgen
Uncovering the Effect of SARS-CoV-2 on Liver Metabolism via Genome-Scale Metabolic Modeling for Reprogramming and Therapeutic Strategies. ACS omega 9 (13) (2024)
Asu Busra Temizer, Gökçe Uludoğan, Rıza Özçelik, Taha Koulani, Elif Ozkirimli, Kutlu O Ülgen, Nilgün Karalı, Arzucan Özgür
Exploring data-driven chemical SMILES tokenization approaches to identify key protein-ligand binding moieties. Molecular informatics 43 (3) (2024)
Mustafa Sertbas, Kutlu O Ülgen
Uncovering the Effect of SARS-CoV-2 on Liver Metabolism via Genome-Scale Metabolic Modeling for Reprogramming and Therapeutic Strategies. ACS omega 9 (13) (2024)
Ilkay Irem Ozbek, Hale Saybasili, Kutlu O Ülgen
Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma. ACS biomaterials science & engineering 10 (5) (2024)
Ilkay Irem Ozbek, Hale Saybasili, Kutlu O Ülgen
Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma. ACS biomaterials science & engineering 10 (5) (2024)
Ozlem Ozbek, Destina Ekingen Genc, Kutlu O Ülgen
Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling of Nanomaterials. ACS pharmacology & translational science 7 (8) (2024)
Ozlem Ozbek, Destina Ekingen Genc, Kutlu O Ülgen
Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling of Nanomaterials. ACS pharmacology & translational science 7 (8) (2024)
Ilkay Irem Ozbek, Hale Saybasili, Kutlu O Ülgen
Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma. ACS biomaterials science & engineering 10 (5) (2024)
Ilkay Irem Ozbek, Kutlu O Ülgen
Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model. Molecules (Basel, Switzerland) 28 (2) (2023)
Elif Esvap, Kutlu O Ülgen
Neuroinflammation, Energy and Sphingolipid Metabolism Biomarkers Are Revealed by Metabolic Modeling of Autistic Brains. Biomedicines 11 (2) (2023)
Elif Esvap, Kutlu O Ülgen
Neuroinflammation, Energy and Sphingolipid Metabolism Biomarkers Are Revealed by Metabolic Modeling of Autistic Brains. Biomedicines 11 (2) (2023)
Ilkay Irem Ozbek, Kutlu O Ülgen
Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model. Molecules (Basel, Switzerland) 28 (2) (2023)
Elif Esvap, Kutlu O Ülgen
Neuroinflammation, Energy and Sphingolipid Metabolism Biomarkers Are Revealed by Metabolic Modeling of Autistic Brains. Biomedicines 11 (2) (2023)
Ezgi Taş, Kutlu O Ülgen
Understanding the ADHD-Gut Axis by Metabolic Network Analysis. Metabolites 13 (5) (2023)
Ilkay Irem Ozbek, Kutlu O Ülgen
Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model. Molecules (Basel, Switzerland) 28 (2) (2023)
Ilkay Irem Ozbek, Kutlu O Ülgen
Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model. Molecules (Basel, Switzerland) 28 (2) (2023)
Ekin Yurdakul, Yaman Barlas, Kutlu O Ülgen
Circadian clock crosstalks with autism. Brain and behavior (2023)
Basak Atas, Cemile Selin Aksoy, Fatma Gizem Avci, Nihat Alpagu Sayar, Kutlu O Ülgen, Elif Ozkirimli, Berna Sariyar Akbulut
Carvacrol Enhances the Antimicrobial Potency of Berberine in Bacillus subtilis. Current microbiology 79 (5) (2022)
Elif Gencturk, Muge Kasim, Berna Morova, Alper Kiraz, Kutlu O Ülgen
Understanding the Link between Inflammasome and Apoptosis through the Response of THP-1 Cells against Drugs Using Droplet-Based Microfluidics. ACS omega 7 (19) (2022)
Elif Esvap, Kutlu O Ülgen
Advances in Genome-Scale Metabolic Modeling toward Microbial Community Analysis of the Human Microbiome. ACS synthetic biology 10 (9) (2021)
Elif Gencturk, Kutlu O Ülgen, Senol Mutlu
Thermoplastic microfluidic bioreactors with integrated electrodes to study tumor treating fields on yeast cells. Biomicrofluidics 14 (3) (2020)

Kutlu O Ülgen.css-eqlu8i{font-size:small;padding-left:4px;} (Kutlu O Ulgen, Kutlu O Ulgen, Kutlu Ulgen)

Publication Activity (10 Years)

Top Topics

Top Venues

Kutlu O Ülgen (Kutlu O Ulgen, Kutlu O Ulgen, Kutlu Ulgen)